A shortage of the antianxiety medication buspirone (Buspar, Bristol-Myers Squibb) has left patients who have anxiety disorders in the lurch as psychiatrists scramble to find suitable alternative ...
Cingulate has posted pharmacokinetic data from an early-phase clinical trial of its triple-release anxiety drug candidate, providing itself with a platform to support development of a planned ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results